Skip to main content
Erschienen in: Osteoporosis International 2/2015

01.02.2015 | Letter

Fear of medication side effects is a barrier to optimal osteoporosis care

verfasst von: A. A. Sheltawy, S. Criseno, N. J. Gittoes, R. K. Crowley

Erschienen in: Osteoporosis International | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Majumdar SR, McAlister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA, Russell AS, Rowe BH (2014) Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int 25:2173–2179. doi:10.1007/s00198-014-2728-z PubMedCrossRef Majumdar SR, McAlister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA, Russell AS, Rowe BH (2014) Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int 25:2173–2179. doi:10.​1007/​s00198-014-2728-z PubMedCrossRef
2.
Zurück zum Zitat Watts NB, Roux C, Modlin JF, Brown JP, Daniels A, Jackson S, Smith S, Zack DJ, Zhou L, Grauer A, Ferrari S (2012) Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association? Osteoporos Int 23:327–337. doi:10.1007/s00198-011-1755-2 PubMedCentralPubMedCrossRef Watts NB, Roux C, Modlin JF, Brown JP, Daniels A, Jackson S, Smith S, Zack DJ, Zhou L, Grauer A, Ferrari S (2012) Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association? Osteoporos Int 23:327–337. doi:10.​1007/​s00198-011-1755-2 PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. doi:10.1007/s11657-013-0136-1 PubMedCentralPubMedCrossRef Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. doi:10.​1007/​s11657-013-0136-1 PubMedCentralPubMedCrossRef
Metadaten
Titel
Fear of medication side effects is a barrier to optimal osteoporosis care
verfasst von
A. A. Sheltawy
S. Criseno
N. J. Gittoes
R. K. Crowley
Publikationsdatum
01.02.2015
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 2/2015
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-2922-z

Weitere Artikel der Ausgabe 2/2015

Osteoporosis International 2/2015 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.